InMed Pharmaceuticals (INM) EPS (Basic) (2021 - 2026)
InMed Pharmaceuticals' (INM) quarterly EPS (Basic) came in at -$0.04 in Q1 2026, up 12.25% year-on-year from -$0.04 in Q1 2025, and up 91.59% quarter-over-quarter from -$0.51 in Q4 2025.
InMed Pharmaceuticals (INM) EPS (Basic) (2021 - 2026) Analysis & Trends
InMed Pharmaceuticals' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.04 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 12.25% year-over-year to -$0.04 in Q1 2026; TTM through Mar 2026 was -$1.29, a 77.27% increase from a year earlier, with the FY2025 full-year figure at -$8.36, up 58.48% from the prior year.
- EPS (Basic) rose to -$0.04 in Q1 2026 per INM's latest filing, from -$0.51 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.04 in Q1 2026 and bottomed at -$280.66 in Q2 2022.
- The 5-year median for EPS (Basic) is -$3.64 (2024), against an average of -$32.58.
- Across the five-year window, EPS (Basic) jumped 99.02% in 2023 and sank 84.27% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$18.24 in 2022, then surged by 79.67% to -$3.71 in 2023, then gained by 1.71% to -$3.64 in 2024, then soared by 85.93% to -$0.51 in 2025, then jumped by 91.59% to -$0.04 in 2026.
- Per Business Quant, the three latest INM EPS (Basic) figures stand at -$0.04 (Q1 2026), -$0.51 (Q4 2025), and -$0.44 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -1.34 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | -3.64 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -5.07 |
| Mar 31, 2024 | -3.58 |
| Dec 31, 2023 | -3.71 |
| Sep 30, 2023 | -15.24 |
| Jun 30, 2023 | -2.75 |
| Mar 31, 2023 | -12.00 |
| Dec 31, 2022 | -18.24 |
| Sep 30, 2022 | -81.10 |
| Jun 30, 2022 | -280.66 |
| Mar 31, 2022 | -122.80 |
| Dec 31, 2021 | -154.64 |
| Sep 30, 2021 | -123.33 |